News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
730,286 Results
Type
Article (42795)
Company Profile (281)
Press Release (687200)
Multimedia
Podcasts (82)
Webinars (17)
Section
Business (206837)
Career Advice (2053)
Deals (35846)
Drug Delivery (110)
Drug Development (81759)
Employer Resources (173)
FDA (16543)
Job Trends (15135)
News (349760)
Policy (33184)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2650)
Academic (1)
Accelerated approval (31)
Adcomms (24)
Allergies (143)
Alliances (50384)
ALS (169)
Alzheimer's disease (1682)
Antibody-drug conjugate (ADC) (308)
Approvals (16808)
Artificial intelligence (518)
Autoimmune disease (153)
Automation (39)
Bankruptcy (365)
Best Places to Work (11706)
BIOSECURE Act (20)
Biosimilars (188)
Biotechnology (180)
Bladder cancer (157)
Brain cancer (57)
Breast cancer (640)
Cancer (4823)
Cardiovascular disease (403)
Career advice (1737)
Career pathing (37)
CAR-T (280)
CDC (44)
Celiac Disease (2)
Cell therapy (741)
Cervical cancer (37)
Clinical research (69748)
Collaboration (1716)
Company closure (4)
Compensation (1156)
Complete response letters (54)
COVID-19 (2760)
CRISPR (89)
C-suite (849)
Cystic fibrosis (143)
Data (6227)
Decentralized trials (2)
Denatured (26)
Depression (132)
Diabetes (501)
Diagnostics (6868)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (255)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (232)
Earnings (90614)
Editorial (56)
Employer branding (21)
Employer resources (152)
Events (118081)
Executive appointments (979)
FDA (19655)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1480)
Gene editing (197)
Generative AI (43)
Gene therapy (596)
GLP-1 (977)
Government (4708)
Grass and pollen (6)
Guidances (383)
Healthcare (19007)
HIV (59)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (250)
Immuno-oncology (57)
Indications (110)
Infectious disease (3032)
Inflammatory bowel disease (188)
Inflation Reduction Act (14)
Influenza (117)
Intellectual property (249)
Interviews (319)
IPO (16713)
IRA (50)
Job creations (3764)
Job search strategy (1455)
JPM (58)
Kidney cancer (16)
Labor market (85)
Layoffs (550)
Leadership (32)
Legal (8067)
Liver cancer (91)
Longevity (14)
Lung cancer (650)
Lymphoma (375)
Machine learning (42)
Management (59)
Manufacturing (791)
MASH (164)
Medical device (13836)
Medtech (13889)
Mergers & acquisitions (20206)
Metabolic disorders (1269)
Multiple sclerosis (160)
NASH (17)
Neurodegenerative disease (315)
Neuropsychiatric disorders (88)
Neuroscience (2909)
Neurotech (1)
NextGen: Class of 2026 (6557)
Non-profit (4572)
Now hiring (67)
Obesity (595)
Opinion (261)
Ovarian cancer (167)
Pain (197)
Pancreatic cancer (229)
Parkinson's disease (280)
Partnered (34)
Patents (495)
Patient recruitment (487)
Peanut (57)
People (59511)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21759)
Phase 2 (30677)
Phase 3 (22860)
Pipeline (5283)
Policy (281)
Postmarket research (2585)
Preclinical (9315)
Press Release (67)
Prostate cancer (238)
Psychedelics (48)
Radiopharmaceuticals (280)
Rare diseases (834)
Real estate (6167)
Recruiting (70)
Regulatory (24788)
Reports (52)
Research institute (2450)
Resumes & cover letters (353)
Rett syndrome (27)
RNA editing (16)
RSV (77)
Schizophrenia (148)
Series A (240)
Series B (190)
Service/supplier (11)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (158)
Sponsored (44)
Startups (3660)
State (2)
Stomach cancer (17)
Supply chain (105)
Tariffs (84)
The Weekly (54)
Vaccines (1005)
Venture capital (88)
Weight loss (381)
Women's health (91)
Worklife (18)
Date
Today (213)
Last 7 days (628)
Last 30 days (2148)
Last 365 days (30126)
2026 (3389)
2025 (30317)
2024 (35418)
2023 (40335)
2022 (51427)
2021 (56014)
2020 (54491)
2019 (46959)
2018 (35322)
2017 (32505)
2016 (31974)
2015 (38000)
2014 (31857)
2013 (26979)
2012 (29100)
2011 (29777)
2010 (27816)
Location
Africa (753)
Alabama (83)
Alaska (7)
Arizona (312)
Arkansas (13)
Asia (40028)
Australia (6550)
California (11316)
Canada (3291)
China (1101)
Colorado (479)
Connecticut (476)
Delaware (336)
Europe (86546)
Florida (1688)
Georgia (356)
Hawaii (3)
Idaho (61)
Illinois (862)
India (65)
Indiana (521)
Iowa (22)
Japan (429)
Kansas (126)
Kentucky (39)
Louisiana (26)
Maine (72)
Maryland (1387)
Massachusetts (8108)
Michigan (324)
Minnesota (633)
Mississippi (5)
Missouri (137)
Montana (35)
Nebraska (28)
Nevada (123)
New Hampshire (79)
New Jersey (3008)
New Mexico (29)
New York (2979)
North Carolina (1470)
North Dakota (8)
Northern California (5515)
Ohio (341)
Oklahoma (21)
Oregon (41)
Pennsylvania (2280)
Puerto Rico (24)
Rhode Island (47)
South America (1138)
South Carolina (66)
South Dakota (1)
Southern California (4412)
Tennessee (174)
Texas (1746)
United States (40133)
Utah (337)
Vermont (1)
Virginia (261)
Washington D.C. (81)
Washington State (921)
West Virginia (4)
Wisconsin (108)
Wyoming (2)
730,286 Results for "prometheus laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Prometheus Laboratories Announces New Health Plan Agreements to Provide Precision-Guided Testing Services
Prometheus Laboratories Inc. announced the execution of provider agreements with three large regional health plans to facilitate access to PredictrPK®, precision-guided biologic testing, and other Prometheus testing services to the participating health plans and their respective members.
May 9, 2024
·
2 min read
Press Releases
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 3, 2026
December 4, 2025
·
1 min read
Press Releases
Mesa Laboratories, Inc. to Participate in Upcoming Investor Conferences - November 12, 2025
November 13, 2025
·
1 min read
Press Releases
Cambridge Isotope Laboratories, Inc. and Chemtatva Chiral Solutions Pvt. Ltd. to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad, India
October 28, 2025
·
3 min read
Business
Prometheus Laboratories Announces Collaboration with Fresenius Kabi on Anser Testing
Prometheus Laboratories Inc. today announced a collaboration with Fresenius Kabi to support the validation of and access to Anser therapeutic drug monitoring (TDM) services for eligible patients receiving the Fresenius Kabi biosimilar, IDACIO (adalimumab-aacf).
August 1, 2023
·
3 min read
Biotech Beach
Prometheus Laboratories Announces the Launch of PredictrPK ADA, A Precision-Guided Dosing Test for Optimization of Adalimumab
Prometheus Laboratories Inc. announced the launch of PredictrPK ADA, a precision-guided dosing test for adult Crohn’s disease (CD) patients receiving ADA treatment.
July 27, 2023
·
4 min read
Press Releases
Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2025
October 5, 2025
·
1 min read
Deals
Merck Completes Acquisition of Prometheus Biosciences, Inc.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the Prometheus Biosciences, Inc. (“Prometheus”) (NASDAQ: RXDX) acquisition.
June 16, 2023
·
6 min read
Press Releases
Bio-Rad Laboratories, Inc. Co-Founder and Director Emeritus Alice Schwartz Passes Away
September 29, 2025
·
1 min read
Press Releases
Cambridge Isotope Laboratories, Inc. Unveils ISOAPI-D - a New Standard in Deuterated Reagents for Pharmaceutical Innovation - at CPhI Frankfurt 2025
October 28, 2025
·
3 min read
1 of 73,029
Next
